Post Tagged with: "Azacitidine"

Preventing Infections in Higher-Risk Myelodysplastic Syndrome Patients Treated with Hypomethylation Agents

Preventing Infections in Higher-Risk Myelodysplastic Syndrome Patients Treated with Hypomethylation Agents

Hematology December 29, 2013 at 5:21 PM 0 comments

Yishai Ofran Department of Hematology and Bone Marrow Transplantation; Rambam Health Care Campus. Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Citation: EMJ Hema. 2013;1:58-63. Abstract Hypomethylation agents became the standard of care for patients with high-risk myelodysplastic syndrome (MDS). While long-term benefits of azacitidine (AZA) and decitabine (DEC) wereRead More